Stoke Therapeutics STOK
NASDAQ STOK
$25.62 -0.39 (-1.50%)
At close: Oct 2, 2026 · 4:00 PM EDT

Stoke Therapeutics (STOK) Selling, General & Administrative (2018 - 2026)

Updated

Stoke Therapeutics' Selling, General & Administrative came in at $25.25 million for Q2 2026, up 65.5% from $15.26 million a year earlier and up 26.4% from the prior quarter.

Analysis

Stoke Therapeutics (STOK) Selling, General & Administrative (2018 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Stoke Therapeutics reported Selling, General & Administrative of $82.4 million, up 48.6% year-over-year; for FY2025, it was $67.09 million, up 37.5% from FY2024.

  • Selling, General & Administrative has increased in each of the last seven years, with a five-year compound annual growth rate of 26.3% (FY2020 to FY2025).
  • Going back by year, Selling, General & Administrative was $48.79 million in FY2024 (+18.1%), $41.32 million in FY2023 (+6.2%), $38.92 million in FY2022 (+22.0%) and $31.9 million in FY2021 (+53.0%).
  • The Q2 2026 figure represents the highest quarterly Selling, General & Administrative in data going back to Q2 2018.
  • Year-over-year, Selling, General & Administrative has increased for 29 consecutive quarters, with growth averaging 37.2% over the last eight quarters.
  • Over the past five years, the year-over-year growth in Selling, General & Administrative ranged from 0.1% (Q1 2024) to 65.5% (Q2 2026).
  • Business Quant data shows STOK's Selling, General & Administrative at $19.97 million (Q1 2026), $21.15 million (Q4 2025) and $16.03 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 6.43 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.63 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -5.65 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.92 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 3.41 Bn
10 Stoke Therapeutics 1.60 Bn 429.41 Mn - 25.25 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 25.25 Mn
Mar 31, 2026 19.97 Mn
Dec 31, 2025 21.15 Mn
Sep 30, 2025 16.03 Mn
Jun 30, 2025 15.26 Mn
Mar 31, 2025 14.65 Mn
Dec 31, 2024 12.84 Mn
Sep 30, 2024 12.69 Mn
Jun 30, 2024 13.04 Mn
Mar 31, 2024 10.22 Mn
Dec 31, 2023 10.61 Mn
Sep 30, 2023 10.27 Mn
Jun 30, 2023 10.23 Mn
Mar 31, 2023 10.21 Mn
Dec 31, 2022 9.38 Mn
Sep 30, 2022 9.94 Mn
Jun 30, 2022 10.11 Mn
Mar 31, 2022 9.49 Mn
Dec 31, 2021 8.72 Mn
Sep 30, 2021 8.33 Mn
API Access

Stoke Therapeutics Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=STOK&period=max&api_key=YOUR_API_KEY